Stocktoria
RESMED INC RMD
NYSE · XNYS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 1995-06-01
RESMED INC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $5.1B | $4.7B | $4.2B | $3.6B | $3.2B |
| Gross profit | $3.1B | $2.7B | $2.4B | $2.0B | $1.8B |
| R&D expense | $331.3M | $307.5M | $287.6M | $253.6M | $225.3M |
| SG&A expense | $991.0M | $917.1M | $874.0M | $737.5M | $670.4M |
| Operating income | $1.7B | $1.3B | $1.1B | $1.0B | $903.7M |
| Interest expense | — | — | — | — | $24.0M |
| Income tax | $276.8M | $243.8M | $204.1M | $181.0M | $409.2M |
| Net income | $1.4B | $1.0B | $897.6M | $779.4M | $474.5M |
| EPS (diluted) | $9.51 | $6.92 | $6.09 | $5.30 | $3.24 |
| Operating cash flow | $1.8B | $1.4B | $693.3M | $351.1M | $736.7M |
| Free cash flow | $1.7B | $1.3B | $573.6M | $216.3M | $634.0M |
| Cash & equivalents | $1.2B | $238.4M | $227.9M | $273.7M | $295.3M |
| Inventory | $927.7M | $822.2M | $998.0M | $743.9M | $457.0M |
| Total assets | $8.2B | $6.9B | $6.8B | $5.1B | $4.7B |
| Total liabilities | $2.2B | $2.0B | $2.6B | $1.7B | $1.8B |
| Shareholders' equity | $6.0B | $4.9B | $4.1B | $3.4B | $2.9B |
Source: SEC EDGAR filings · CIK 0000943819 · as of 2025-06-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.